Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose Two-Drug Regimen Versus Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1: Phase 3, Randomized, Non-inferiority TANGO Study

(2020) Jean van Wyk et al.   CLINICAL INFECTIOUS DISEASES

Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice

(2019) Gianmaria Baldin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success

(2019) Claudia Alteri et al.   JOURNAL OF CLINICAL VIROLOGY

HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients

(2018) Jonathan L. Golob et al.   AIDS

Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients

(2018) Barbara Rossetti et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication

(2018) A Borghetti et al.   HIV MEDICINE

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

(2018) Véronique Joly et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation

(2017) Rajesh T. Gandhi et al.   PLoS Pathogens

Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

(2016) Véronique Avettand-Fènoël et al.   CLINICAL MICROBIOLOGY REVIEWS

CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients

(2015) Wei Lu et al.   Journal of the International AIDS Society

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

(2015) Cristina Mussini et al.   Lancet HIV

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

(2014) Guillaume J. Besson et al.   CLINICAL INFECTIOUS DISEASES

Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, ‘definetherain’

(2014) Mathew Jones et al.   JOURNAL OF VIROLOGICAL METHODS

Highly Precise Measurement of HIV DNA by Droplet Digital PCR

(2013) Matthew C. Strain et al.   PLoS One

How to best measure HIV reservoirs?

(2013) Christine Rouzioux et al.   Current Opinion in HIV and AIDS